Press Releases

Hero overlay Cancer research Analyst Coverage Annual Report Proxy Materials Corporate Governance Events Presentations Financial Information Investor Disclaimer Press Releases Stock Information
New Program Expands Access to PacBio's Highly Accurate Sequencing Systems by Providing Flexible Financing   MENLO PARK, Calif. , Sept. 12, 2023 /PRNewswire/ -- PacBio  (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced PacBio Capital , a
September 12, 2023
MENLO PARK, Calif. , Aug. 9, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:     UBS MedTech, Tools and Genomics Summit 2023
August 9, 2023
MENLO PARK, Calif. , Aug. 2, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023 .     Second quarter  results Revenue of $47.6 million , a 34% increase compared with $35.5 million in the prior year-period.
August 2, 2023

Investor Contact

Pacific Biosciences of California, Inc.
1305 O’Brien Drive, Menlo Park, CA 94025
ir@pacb.com